201 related articles for article (PubMed ID: 35963815)
21. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
22. Dendritic-tumor fusion cells in cancer immunotherapy.
Takakura K; Kajihara M; Ito Z; Ohkusa T; Gong J; Koido S
Discov Med; 2015 Mar; 19(104):169-74. PubMed ID: 25828520
[TBL] [Abstract][Full Text] [Related]
23. Pyroptosis Remodeling Tumor Microenvironment to Enhance Pancreatic Cancer Immunotherapy Driven by Membrane Anchoring Photosensitizer.
Wang M; Wu M; Liu X; Shao S; Huang J; Liu B; Liang T
Adv Sci (Weinh); 2022 Oct; 9(29):e2202914. PubMed ID: 35981886
[TBL] [Abstract][Full Text] [Related]
24. Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy.
Li J; Zhao M; Liang W; Wu S; Wang Z; Wang D
J Control Release; 2022 Feb; 342():308-320. PubMed ID: 35031387
[TBL] [Abstract][Full Text] [Related]
25. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
[TBL] [Abstract][Full Text] [Related]
26. Reversing the immunosuppressive microenvironment with reduced redox level by microwave-chemo-immunostimulant Ce-Mn MOF for improved immunotherapy.
Zeng Z; Fu C; Sun X; Niu M; Ren X; Tan L; Wu Q; Huang Z; Meng X
J Nanobiotechnology; 2022 Dec; 20(1):512. PubMed ID: 36463157
[TBL] [Abstract][Full Text] [Related]
27. Colorectal Tumor Microenvironment-Activated Bio-Decomposable and Metabolizable Cu
Chang M; Hou Z; Jin D; Zhou J; Wang M; Wang M; Shu M; Ding B; Li C; Lin J
Adv Mater; 2020 Oct; 32(43):e2004647. PubMed ID: 32945002
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
29. Converting bacteria into autologous tumor vaccine
Guo L; Ding J; Zhou W
Acta Pharm Sin B; 2023 Dec; 13(12):5074-5090. PubMed ID: 38045045
[TBL] [Abstract][Full Text] [Related]
30. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
31. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
32. Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Tian LR; Lin MZ; Zhong HH; Cai YJ; Li B; Xiao ZC; Shuai XT
Biomater Sci; 2022 Jul; 10(14):3892-3900. PubMed ID: 35686599
[TBL] [Abstract][Full Text] [Related]
33. Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy.
Qing S; Lyu C; Zhu L; Pan C; Wang S; Li F; Wang J; Yue H; Gao X; Jia R; Wei W; Ma G
Adv Mater; 2020 Nov; 32(47):e2002085. PubMed ID: 33015871
[TBL] [Abstract][Full Text] [Related]
34. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy.
Gao C; Cheng K; Li Y; Gong R; Zhao X; Nie G; Ren H
Nano Lett; 2022 Nov; 22(22):8801-8809. PubMed ID: 36251255
[TBL] [Abstract][Full Text] [Related]
35. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
36. A DNA vaccine expressing an optimized secreted FAPα induces enhanced anti-tumor activity by altering the tumor microenvironment in a murine model of breast cancer.
Geng F; Guo J; Guo QQ; Xie Y; Dong L; Zhou Y; Liu CL; Yu B; Wu H; Wu JX; Zhang HH; Kong W; Yu XH
Vaccine; 2019 Jul; 37(31):4382-4391. PubMed ID: 31202521
[TBL] [Abstract][Full Text] [Related]
37. Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy.
Chen G; Xiong W; Gu Z; Gao Y; Hou J; Long L; Wang H; Asrorov AM; Muhitdinov B; Xu Q; Huang Y
Int J Biol Macromol; 2022 Dec; 223(Pt A):1485-1494. PubMed ID: 36395942
[TBL] [Abstract][Full Text] [Related]
38. An in situ hydrogel-mediated chemo-immunometabolic cancer therapy.
Wang B; Chen J; Caserto JS; Wang X; Ma M
Nat Commun; 2022 Jul; 13(1):3821. PubMed ID: 35780226
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Remodeling Hydrogel Patches for Multidrug-Resistant Triple-Negative Breast Cancer.
Ji X; Guo D; Ma J; Yin M; Yu Y; Liu C; Zhou Y; Sun J; Li Q; Chen N; Fan C; Song H
Adv Mater; 2021 May; 33(18):e2100949. PubMed ID: 33792093
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
